All Programs

Use the tool below to view all available Rheumatology Academy Series

Sjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
Sjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
CME/CE
Sjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
Chadwick R. Johr, MD
1.00 credit
- Chadwick R. Johr, MD
1.00 credit
Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Living Rheum
Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Avery H. LaChance, MD, MPH, FAAD
- Avery H. LaChance, MD, MPH, FAAD
The Cardiovascular Dimension of Psoriatic Arthritis
The Cardiovascular Dimension of Psoriatic Arthritis
Living Rheum
The Cardiovascular Dimension of Psoriatic Arthritis
Understanding Difficult-to-Treat Axial Spondyloarthritis in Real-World Practice
Understanding Difficult-to-Treat Axial Spondyloarthritis in Real-World Practice
Living Rheum
Understanding Difficult-to-Treat Axial Spondyloarthritis in Real-World Practice
Measuring What Matters in Psoriatic Arthritis
Measuring What Matters in Psoriatic Arthritis
Living Rheum
Measuring What Matters in Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
- Laura Coates, MBChB, MRCP, PhD
The Next Era of Psoriatic Arthritis Management
The Next Era of Psoriatic Arthritis Management
Living Rheum
The Next Era of Psoriatic Arthritis Management
Laura Coates, MBChB, MRCP, PhD
- Laura Coates, MBChB, MRCP, PhD
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
Living Rheum
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
- Laura Coates, MBChB, MRCP, PhD
Shared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Shared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Living Rheum
Shared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Spotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
Spotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
CME/CE
Spotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
Flavia Castelino, MD; Benjamin Korman, MD
1.00 credit
- Flavia Castelino, MD
- Benjamin Korman, MD
1.00 credit
Navigating the Modern PsA Treatment Landscape
Navigating the Modern PsA Treatment Landscape
Living Rheum
Navigating the Modern PsA Treatment Landscape
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
AudioAbstracts
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
Ryan Quigley
- Ryan Quigley
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Living Rheum
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Steve Jackson, PharmD; Marc Scherlinger, MD, PhD
- Steve Jackson, PharmD
- Marc Scherlinger, MD, PhD
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Living Rheum
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Gary S. Firestein, MD
- Gary S. Firestein, MD
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Living Rheum
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Gary S. Firestein, MD
- Gary S. Firestein, MD
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
DermConsult
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Living Rheum
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings

All Programs

Popular

CONTACT US

(866) 423-7849

CONTACT US

(866) 423-7849

All Programs

Popular

Title